A histamine H2 receptor antagonist and major active metabolite of roxatidine acetate
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Roxatidine

Item No. 36111

Technical Information
Formal Name
2-hydroxy-N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]-acetamide
CAS Number
78273-80-0
Molecular Formula
C17H26N2O3
Formula Weight
Purity
≥95%
A neat oil
DMSO: up to 25 mg/ml
SMILES
O=C(CO)NCCCOC1=CC=CC(CN2CCCCC2)=C1
InChi Code
InChI=1S/C17H26N2O3/c20-14-17(21)18-8-5-11-22-16-7-4-6-15(12-16)13-19-9-2-1-3-10-19/h4,6-7,12,20H,1-3,5,8-11,13-14H2,(H,18,21)
InChi Key
BCCREUFCSIMJFS-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Roxatidine is a histamine H2 receptor antagonist and major active metabolite of roxatidine acetate (Item No. 21248).1 Roxatidine reduces histamine-induced adenylate cyclase production in guinea pig parietal cells (IC50 = 0.8 µM). It inhibits histamine-induced hydrogen ion accumulation in the same cells (pA2 = 7.03). Roxatidine (200 mg/kg) reduces small intestinal lesion area in a rat model of gastric mucosal injury induced by indomethacin (Item No. 70270).2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sewing, K.-F., Beil, W., and Hannemann, H. Comparative pharmacology of histamine H2-receptor antagonists. Drugs 35(Suppl. 3), 25-29 (1988).

    2. Umegaki, E., Yoda, Y., Tokioka, S., et alProtective effect of roxatidine against indomethacin induced small intestinal mucosal injury in rats. J. Gastroenterol. Hepatol. 25(Suppl. 1), S35-S40 (2010).